Anika Therapeutics Inc share price logo

Anika Therapeutics Inc Share Price

NASDAQ: ANIK

Small Cap

$8.65

+0.02

(+0.23%)

as on

Anika Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $8.52
    $8.71
    downward going graph

    1.50%

    Downside

    0.69%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.87
    $26
    downward going graph

    9.02%

    Downside

    200.58%

    Upside

    downward going graph

Anika Therapeutics Inc share price movements today

Previous Close
$8.63
Open
$8.58
Volume
132.6K
Day's Low - High
$8.52 - $8.71
52 Week Low - High
$7.87 - $26

Anika Therapeutics Inc Historical Returns

1 Month Return
-4.52 %
3 Month Return
-20.68 %
1 Year Return
-64.81 %
3 Year Return
-61 %
5 Year Return
-76.22 %

Anika Therapeutics Inc Stock Fundamentals & Key Indicators

Check Anika Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$125.0M

EPS (TTM)

-0.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.51%

PE Ratio (TTM)

-5.11

Industry PE ratio

-3.773885542168675

P/B Ratio

0

PEG Ratio

4.7944

EBITDA

-1.6M

Revenue (TTM)

114.5M

Profit Margin

-52.93%

Return On Equity TTM

35064100.00%

Anika Therapeutics Inc Stock Valuation

Track how Anika Therapeutics Inc P/E has moved over time to understand its valuation trends.

Anika Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (50.85x)

September 30, 2021

Today (-5.11x)

September 13, 2025

Industry (-3.77x)

September 13, 2025

Highest (138.02x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.11x

Anika Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anika Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$125.0M-76.22%-5.11-52.93%
BUY$18.3BNA15.840.36%
BUY$44.2BNA21.9313.81%
BUY$14.1B41.32%41.9713.88%
BUY$65.7B-6.55%25.5127.83%

Stock Returns calculator for Anika Therapeutics Inc Stock including INR - Dollar returns

The Anika Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anika Therapeutics Inc investment value today

Current value as on today

₹40,245

Returns

₹59,755

(-59.76%)

Returns from Anika Therapeutics Inc Stock

₹64,894 (-64.89%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Anika Therapeutics Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Anika Therapeutics Inc. Average target price of $17.33

Anika Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Anika Therapeutics Inc.

What analysts predicted

50.09%UPSIDE

Target Price

$17.33

Current Price

$8.65

Analyzed by

9 Analysts

Target

$17.33

Anika Therapeutics Inc target price $17.33, a slight upside of 50.09% compared to current price of $8.65. According to 9 analysts rating.

Anika Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Anika Therapeutics Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Anika Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
37
44
41
42
40
41
38
30
26
28
Gross Profit
22
28
24
26
24
27
1
22
14
14
Operating Income
-12
-3
-7
-63
-5
0
-28
27
-4
-4
EBITDA
-9
0
-4
28
-1
2
-25
1
-2
-2
Interest Expense
0
0
-
1
0
-
-
-
0
0
Depreciation
3
3
3
3
2
2
2
1
1
1
Income Before Tax
-12
-3
-7
-63
-4
0
-27
0
-3
-3
Income Tax Expense
-1
0
0
0
0
0
2
2
0
0
Net Income
-10
-2
-6
-63
-4
0
-29
-21
-4
-3
Net Profit Margin
-27.29%
-6.19%
-15.86%
-146.61%
-11.14%
-0.21%
-77.20%
-71.45%
-18.62%
-14.07%

Anika Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
92
103
113
105
114
130
147
156
166
119
Gross Profit
71
79
86
74
85
69
82
93
82
75
Operating Income
48
50
45
21
34
-28
2
-19
0
-5
EBITDA
51
54
50
27
40
3
2
-4
-11
3
Interest Expense
0
0
0
1
7
0
0
0
2
2
Depreciation
-
-
4
5
5
13
14
14
14
8
Income Before Tax
48
50
46
23
36
-28
2
-18
-85
-2
Income Tax Expense
17
18
14
4
8
-4
-1
-3
-2
6
Net Income
30
32
31
18
27
-23
4
-14
-82
-56
Net Profit Margin
33.07%
31.48%
28.05%
17.74%
23.73%
-18.38%
2.80%
-9.51%
-49.60%
-47.02%

Anika Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-2
-6
-63
-4
0
-29
-21
-4
-3
Operating Cash Flow
-8
6
3
0
-1
5
1
0
0
Investing Cash Flow
-1
0
-1
-1
-3
-1
-1
1
0
Financing Cash Flow
-4
0
0
-2
-1
-3
-5
-5
0
Change in Cash
-14
5
2
-4
-5
0
-5
-3
0

Anika Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
32
31
18
27
-23
4
-14
-82
-56
Operating Cash Flow
23
40
34
37
13
8
4
-1
5
Investing Cash Flow
-6
-12
-50
39
-71
-3
-7
-5
-8
Financing Cash Flow
-23
0
-28
-8
-3
-6
-4
-6
-12
Change in Cash
-6
28
-44
68
-61
-1
-8
-13
-15

Global Institutional Holdings in Anika Therapeutics Inc

Funds
Holdings
Trigran Investments Inc
14.16%
BlackRock Inc
10.54%
Caligan Partners LP
9.95%
Vanguard Group Inc
5.39%
Dimensional Fund Advisors, Inc.
4.26%

Insights on Anika Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 26.16M → 28.21M (in $), with an average increase of 7.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -29.91M → -3.97M (in $), with an average increase of 136.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 83.8% return, outperforming this stock by 145.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.6% return, outperforming this stock by 84.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ANIK stock has moved down by -45.5%

About Anika Therapeutics Inc

who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an
OrganisationAnika Therapeutics Inc
Headquarters32 Wiggins Avenue, Bedford, MA, United States, 01730
IndustryHealth Technology
CEODr. Cheryl Renee Blanchard Ph.D.
E-voting on sharesClick here to vote

Key Management of Anika Therapeutics Inc

Name

Title

Mr. Stephen D. Griffin

Executive VP, CFO & COO

Mr. David Colleran J.D.

Executive VP, General Counsel & Corporate Secretary

Mr. Ben Joseph

Vice President of Commercial & Corporate Development

Dr. Cheryl Renee Blanchard Ph.D.

President, CEO & Director

Mr. Ian W. McLeod

VP & Chief Accounting Officer

Mr. Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Mr. James Chase

Senior Vice President of International Sales & Marketing

Ms. Lisa Funiciello

Vice President of Human Resources

Ms. Mira Leiwant

Senior Vice President of Regulatory, Quality & Clinical Affairs

FAQs

What is Anika Therapeutics Inc share price today?

Anika Therapeutics Inc share price today is $8.65 as on at the close of the market. Anika Therapeutics Inc share today touched a day high of $8.71 and a low of $8.52.

What is the 52 week high and 52 week low for Anika Therapeutics Inc share?

Anika Therapeutics Inc share touched a 52 week high of $26 on and a 52 week low of $7.87 on . Anika Therapeutics Inc stock price today i.e. is closed at $8.65,which is 66.73% down from its 52 week high and 9.91% up from its 52 week low.

What is Anika Therapeutics Inc's market capitalisation today?

Anika Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Anika Therapeutics Inc Stock (ANIK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anika Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anika Therapeutics Inc Shares that will get you 0.1734 shares as per Anika Therapeutics Inc share price of $8.65 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Anika Therapeutics Inc Stock (ANIK) from India?

Indian investors can start investing in Anika Therapeutics Inc (ANIK) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Anika Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Anika Therapeutics Inc share’s latest price of $8.65 as on September 13, 2025 at 1:29 am IST, you will get 1.1561 shares of Anika Therapeutics Inc. Learn more about fractional shares .

What are the returns that Anika Therapeutics Inc has given to Indian investors in the last 5 years?

Anika Therapeutics Inc stock has given -76.22% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?